Meyer Sauteur PM, Zhang X-S, Emborg H-D, Sidorov S, Pereyre S, Fischer A, Lemaire B, Greub G, Zimmermann P, Agyeman PKA et al (2025) Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study. Lancet Microbe 6:101019. https://doi.org/10.1016/j.lanmic.2024.101019

Meyer Sauteur PM, Beeton ML, Pereyre S, Bébéar C, Gardette M, Hénin N, Wagner N, Fischer A, Vitale A, Lemaire B et al (2024) Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae. Lancet Microbe 5:e514. https://doi.org/10.1016/S2666-5247(23)00406-8

Article  PubMed  Google Scholar 

Villa S, Maffeo M, Maistrello M, Bagarella G, Porrello VN, Morani F, Scovenna F, Baldanti F, Bonfanti P, Pariani E et al (2025) Increased pneumonia-related emergency department visits, Northern Italy. Emerg Infect Dis 31:1057–1059. https://doi.org/10.3201/eid3105.241790

Article  PubMed  PubMed Central  Google Scholar 

Meyer Sauteur PM, Krautter S, Ambroggio L, Seiler M, Paioni P, Relly C, Capaul R, Kellenberger C, Haas T, Gysin C et al (2020) Improved diagnostics help to identify clinical features and biomarkers that predict Mycoplasma pneumoniae community-acquired pneumonia in children. Clin Infect Dis 71:1645–1654. https://doi.org/10.1093/cid/ciz1059

Article  CAS  PubMed  Google Scholar 

Meyer Sauteur PM, Sidorov S, Pereyre S, Gardette M, Fischer A, Wagner N, Lemaire B, Vitale A, Greub G, Brouillet R et al (2025) Mycoplasma pneumoniae re-emergence and beyond. Lancet Microbe online ahead of print. https://doi.org/10.1016/j.lanmic.2025.101191

Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M (2014) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg 12:1500–1524. https://doi.org/10.1016/j.ijsu.2014.07.014

Article  PubMed  Google Scholar 

Meyer Sauteur PM, Beeton ML, on behalf of the ESGMAC and the ESGMAC MAPS study group (2023) Mycoplasma pneumoniae: gone forever? Lancet Microbe 4:e763. https://doi.org/10.1016/S2666-5247(23)00182-9

Streng BMM, Bont LJ, Meyer Sauteur PM, Bonten MJM, van Rossum AMC, Prat Aymerich C (2025) Mycoplasma pneumoniae re-emergence in 2023 causes disease in adults in Europe. ERJ Open Res in press. https://doi.org/10.1183/23120541.00585-2025

Novazzi F, Arcari G, Perniciaro S, Boutahar S, Niccolini N, Ferrante FD, Genoni AP, Agosti M, Mancini N (2025) Ongoing post-pandemic peak of Mycoplasma pneumoniae cases in July 2024: a single-center experience in north-west Italy. IJID Reg 14:100554. https://doi.org/10.1016/j.ijregi.2024.100554

Article  PubMed  Google Scholar 

Taborda I, Tomé R, Santos Ferreira C, Oliveira Inácio R, Vaz J, Carmo A, Gata L, Rodrigues F (2025) No increase in severity of Mycoplasma pneumoniae: insights from the postpandemic epidemic. Pediatr Infect Dis J 44:e24–e26. https://doi.org/10.1097/INF.0000000000004545

Article  PubMed  Google Scholar 

Dungu KHS, Holm M, Hartling U, Jensen LH, Nielsen AB, Schmidt LS, Toustrup LB, Hansen LH, Dahl KW, Matthesen KT et al (2024) Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study. Lancet Reg Health Eur 47:101103. https://doi.org/10.1016/j.lanepe.2024.101103

Article  PubMed  PubMed Central  Google Scholar 

Raghuram A, Furmanek S, Chandler T, Rashid S, Mattingly W, Ramirez J (2025) Description of a current outbreak of Mycoplasma pneumoniae in the United States. Pathogens 14:60. https://doi.org/10.3390/pathogens14010060

Article  PubMed  PubMed Central  Google Scholar 

Cha S-I, Shin K-M, Jeon K-N, Yoo S-S, Lee J, Lee S-Y, Kim C-H, Park J-Y, Jung T-H (2012) Clinical relevance and characteristics of pleural effusion in patients with Mycoplasma pneumoniae pneumonia. Scand J Infect Dis 44:793–797. https://doi.org/10.3109/00365548.2012.681696

Article  PubMed  Google Scholar 

Méndez-Echevarría A, Calle-Miguel L, Miralbés S, Barreiro-Pérez S, Afonso-Rodriguez O, Soler-Simón JA, Espeleta-Fox A, Jiménez-Jiménez AB, Méndez-Sánchez A, Rementeria-Radigales JI et al (2024) Increased severity of Mycoplasma pneumoniae infections in Spanish children. Pediatr Infect Dis J 43:1113–1119. https://doi.org/10.1097/INF.0000000000004461

Article  PubMed  Google Scholar 

McCarthy KN, Hatcher J, Best T, Kaliakatsos M, Hassell J, Turnbull A, Sidgwick P, Gavela J, Simmonds J, Kucera F et al (2025) Increasing number of clinically severe Mycoplasma pneumoniae infections in children after the COVID-19 pandemic: a single-center case series. J Pediatr Infect Dis Soc 14:piae132. https://doi.org/10.1093/jpids/piae132

Danner MT, Binns HC, Nguyen K, Johnson C, Dunn J, Niles D, Nguyen DK (2025) Resurgence of pediatric Mycoplasma pneumoniae infections in Southeast Texas, November 2023-June 2024. J Pediatr Infect Dis Soc 14:piae119. https://doi.org/10.1093/jpids/piae119

Same RG, Gerber JS (2025) Walking (pneumonia) down memory lane: Mycoplasma pneumoniae returns. J Pediatr Infect Dis Soc 14:piaf006. https://doi.org/10.1093/jpids/piaf006

Urbieta AD, Barbeito Castiñeiras G, Rivero Calle I, Pardo Seco J, Rodríguez Tenreiro C, Suárez Camacho R, Del Molino P, Bernal ML, Martinón Torres F (2024) Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain. Emerg Microbes Infect 13:2332680. https://doi.org/10.1080/22221751.2024.2332680

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nygaard U, Holm M, Rabie H, Rytter M (2024) The pattern of childhood infections during and after the COVID-19 pandemic. Lancet Child Adolesc Health 8:910–920. https://doi.org/10.1016/S2352-4642(24)00236-0

Article  PubMed  Google Scholar 

Meyer Sauteur PM, Pánisová E, Seiler M, Theiler M, Berger C, Dumke R (2021) Mycoplasma pneumoniae genotypes and clinical outcome in children. J Clin Microbiol 59:e00748–e821. https://doi.org/10.1128/JCM.00748-21

Article  PubMed  PubMed Central  Google Scholar 

Meyer Sauteur PM, Seiler M, Trück J, Unger WWJ, Paioni P, Relly C, Staubli G, Haas T, Gysin C, M. Bachmann L et al (2019) Diagnosis of Mycoplasma pneumoniae pneumonia with measurement of specific antibody-secreting cells. Am J Respir Crit Care Med 200:1066–1069. https://doi.org/10.1164/rccm.201904-0860LE

Meyer Sauteur PM, Bleisch B, Voit A, Maurer F, Relly C, Berger C, Nadal D, Bloemberg G (2014) Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland. Swiss Med Wkly 144. https://doi.org/10.4414/smw.2014.14041

Meyer Sauteur PM, Seiler M, Tilen R, Osuna E, Von Wantoch M, Sidorov S, Aebi C, Agyeman P, Barbey F, Bielicki JA et al (2024) A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study. Trials 25:655. https://doi.org/10.1186/s13063-024-08438-6

Article  CAS  PubMed  PubMed Central  Google Scholar